Dechra Pharmaceuticals Ordinary 1p (DPH)
Search for shares
News, reports & tips
-
Tuesday broker round-up - UPDATE
31 Jan, 2012 10:32
ARM Holdings: Nomura keeps neutral rating and 580p target; Nomura maintains hold rating and 575p target; Peel Hunt keeps hold and 580p target. -
Wednesday broker round-up - UPDATE
11 Jan, 2012 17:03
Unilever: Bank of America Merrill Lynch downgrades to underweight from neutral. -
Margins under pressure at Dechra
11 Jan, 2012 13:10
Veterinary pharmaceutical firm Dechra Pharmaceuticals has reported that group revenue for the six months ended 31 December was around 9.1% ahead of the equivalent period last year. -
Tuesday broker round-up - UPDATE
29 Nov, 2011 10:30
Senior: Credit Suisse keeps at neutral, raises target to 175p from 165p. -
Sunday share tip round-up: Dechra, Aveva, Persimmon
06 Nov, 2011 17:27
The first three months of the financial year started well at animal health-care group Dechra. Revenue in the first quarter is 7.7% ahead of the same period last year, whereas… -
Dechra Pharmaceuticals shrugs off weak economy
06 Sep, 2011 14:46
The reluctance of pet-owners' to neglect their animals despite tough economic conditions helped Dechra Pharmaceuticals post a rise in profits in the year to 30 June. -
Tuesday tips round-up: Ladbrokes, Michael Page, Halma
12 Jul, 2011 06:42
Ladbrokes' shares have suffered this year, by comparison with its main quoted peer, William Hill. One reason for this is William Hill's symbiotic relationship with the gaming IT company Playtech,… -
Dechra expects slight miss in revenue
11 Jul, 2011 14:57
Veterinary pharmaceutical group Dechra Pharmaceuticals expects sales for the year ended 30 June to be 5.1% ahead of last year, slightly under consensus forecasts. -
Dechra on steady growth path
10 May, 2011 12:59
It was more of the same for Dechra Pharmaceuticals in the third quarter of its financial year as the first half's trends continued. -
North America boss offloads Pearson shares
02 Mar, 2011 17:47
A round-up of the biggest director deals today so far. -
Friday tips round-up: National Express, Croda, Ashmore...
25 Feb, 2011 07:00
Finally, some good news for much-troubled National Express. From the doldrums of a scrapped rail franchise and sharp financial losses in 2009, the transport group posted annual results for 2010… -
Small caps round-up: Medusa Mining, Kentz, Central Rand
22 Feb, 2011 14:59
Philippines-focused miner Medusa Mining saw earnings before interest, tax, depreciation and amortisation double to $63.3m in the six months to 31 December 2010 from $31.5m in the second half of…
This news service is operated by Digital Look Ltd. Republication or redistribution of Digital Look Ltd content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Digital Look Ltd. Please see http://www.DigitalLook.com/newsfeedterms for our terms and conditions.
© Digital Look Ltd 1998-2012. All rights reserved.
Prices delayed by at least 15 minutes.
Regulatory announcements
-
Product Acquisition HY-50®
31 Jan, 2012 07:00
Dechra Pharmaceuticals -
Trading Update
11 Jan, 2012 07:00
Dechra Pharmaceuticals -
Total Voting Rights
30 Dec, 2011 07:00
Dechra Pharmaceuticals -
Holding(s) in Company
22 Dec, 2011 17:18
Dechra Pharmaceuticals -
Holding(s) in Company
20 Dec, 2011 16:05
Schroders -
Director/PDMR Shareholding
19 Dec, 2011 16:53
Dechra Pharmaceuticals -
Director/PDMR Shareholding
15 Dec, 2011 10:17
Dechra Pharmaceuticals -
Director/PDMR Shareholding
07 Dec, 2011 14:49
Dechra Pharmaceuticals -
Total Voting Rights
30 Nov, 2011 16:10
Dechra Pharmaceuticals -
FDA Approval for Manufacturing at Dales
29 Nov, 2011 07:00
Dechra Pharmaceuticals -
Result of AGM
04 Nov, 2011 14:38
Dechra Pharmaceuticals -
Interim Management Statement
04 Nov, 2011 07:00
Dechra Pharmaceuticals